These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32998843)

  • 21. Severity of hearing loss after platinum chemotherapy in childhood cancer survivors.
    Strebel S; Mader L; Sláma T; Waespe N; Weiss A; Parfitt R; Am Zehnhoff-Dinnesen A; Kompis M; von der Weid NX; Ansari M; Kuehni CE
    Pediatr Blood Cancer; 2022 Sep; 69(9):e29755. PubMed ID: 35723448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Applications of the Grading Scales for the Detection of Ototoxicity in Children after Treatment of Neuroblastoma and Extracranial Germinal Tumor.
    Polski B; Sosnowska-Sienkiewicz P; Szydłowski J; Januszkiewicz-Lewandowska D
    Audiol Neurootol; 2023; 28(1):32-42. PubMed ID: 36191558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An audit of UK audiological practice in specialist paediatric oncology centres regarding hearing assessment of children at risk of ototoxicity due to chemotherapy.
    Brown ECM; Caimino C; Benton CL; Baguley DM
    J Laryngol Otol; 2021 Jan; 135(1):14-20. PubMed ID: 33487183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Audiological Monitoring in Children Treated with Platinum Chemotherapy.
    Fetoni AR; Ruggiero A; Lucidi D; De Corso E; Sergi B; Conti G; Paludetti G
    Audiol Neurootol; 2016; 21(4):203-211. PubMed ID: 27286730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Baseline audiological profiling of South African females with cervical cancer: an important attribute for assessing cisplatin-associated ototoxicity.
    Paken J; Govender CD; Pillay M; Ayele BT; Sewram V
    BMC Womens Health; 2021 Apr; 21(1):164. PubMed ID: 33879158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sensorineural Hearing Loss in Nasopharyngeal Carcinoma Survivors in the Modern Treatment Era - The Early and Late Effects of Radiation and Cisplatin.
    Yip PL; Mok KCJ; Ho HS; Lee WYV; Wong ACL; Lau CT; Wong FCS; Yeung KW; Lee SF
    Clin Oncol (R Coll Radiol); 2022 Apr; 34(4):e160-e167. PubMed ID: 34772581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
    Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Incidence and Risk Factors of Cisplatin and Carboplatin Ototoxicity in Pediatric Oncology Patients at Tertiary Oncology Center.
    Attar M; Alqarni MS; Alsinnari YM; Bukhari ZM; Alshegifi H; Alzhrani A; Alshaikh K; Alsubaie H; Muqat M; Alhakami H; Algarni M
    Indian J Surg Oncol; 2022 Dec; 13(4):925-930. PubMed ID: 36687225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platinum-induced ototoxicity: a review of prevailing ototoxicity criteria.
    Waissbluth S; Peleva E; Daniel SJ
    Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1187-1196. PubMed ID: 27245751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recommendations for Age-Appropriate Testing, Timing, and Frequency of Audiologic Monitoring During Childhood Cancer Treatment: An International Society of Paediatric Oncology Supportive Care Consensus Report.
    Meijer AJM; van den Heuvel-Eibrink MM; Brooks B; Am Zehnhoff-Dinnesen AG; Knight KR; Freyer DR; Chang KW; Hero B; Papadakis V; Frazier AL; Blattmann C; Windsor R; Morland B; Bouffet E; Rutkowski S; Tytgat GAM; Geller JI; Hunter LL; Sung L; Calaminus G; Carleton BC; Helleman HW; Foster JH; Kruger M; Cohn RJ; Landier W; van Grotel M; Brock PR; Hoetink AE; Rajput KM;
    JAMA Oncol; 2021 Oct; 7(10):1550-1558. PubMed ID: 34383016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platinum Compound-Related Ototoxicity in Children: Long-Term Follow-Up Reveals Continuous Worsening of Hearing Loss.
    Bertolini P; Lassalle M; Mercier G; Raquin MA; Izzi G; Corradini N; Hartmann O
    J Pediatr Hematol Oncol; 2004 Oct; 26(10):649-655. PubMed ID: 27811606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ototoxicity-induced hearing loss and quality of life in survivors of paediatric cancer.
    Rajput K; Edwards L; Brock P; Abiodun A; Simpkin P; Al-Malky G
    Int J Pediatr Otorhinolaryngol; 2020 Nov; 138():110401. PubMed ID: 33152988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ototoxicity monitoring in children treated with platinum chemotherapy.
    Brooks B; Knight K
    Int J Audiol; 2018 Sep; 57(sup4):S34-S40. PubMed ID: 28737048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale.
    Brock PR; Knight KR; Freyer DR; Campbell KC; Steyger PS; Blakley BW; Rassekh SR; Chang KW; Fligor BJ; Rajput K; Sullivan M; Neuwelt EA
    J Clin Oncol; 2012 Jul; 30(19):2408-17. PubMed ID: 22547603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Study on Prevalence and Determinants of Ototoxicity During Treatment of Childhood Cancer (SOUND): Protocol for a Prospective Study.
    Diepstraten FA; Meijer AJ; van Grotel M; Plasschaert S; Hoetink AE; Fiocco M; Janssens GO; Stokroos RJ; van den Heuvel-Eibrink MM
    JMIR Res Protoc; 2022 Apr; 11(4):e34297. PubMed ID: 35389352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hearing loss in children with brain tumors treated with cisplatin and carboplatin-based high-dose chemotherapy with autologous bone marrow rescue.
    Freilich RJ; Kraus DH; Budnick AS; Bayer LA; Finlay JL
    Med Pediatr Oncol; 1996 Feb; 26(2):95-100. PubMed ID: 8531860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ototoxicity and long-term hearing outcome in pediatric patients receiving cisplatin.
    Sriyapai T; Thongyai K; Phuakpet K; Vathana N; Buaboonnam J; Sanpakit K
    Turk J Pediatr; 2022; 64(3):531-541. PubMed ID: 35899566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions.
    Knight KR; Kraemer DF; Winter C; Neuwelt EA
    J Clin Oncol; 2007 Apr; 25(10):1190-5. PubMed ID: 17401008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficacy of intratympanic infiltration of N-acetyl cysteine in cisplatin ototoxicity].
    Rosas-Gutiérrez GDC; Fernández-Hernández JP; Olea-González AI
    Rev Med Inst Mex Seguro Soc; 2023 Sep; 61(Suppl 2):S318-S322. PubMed ID: 38016189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different infusion durations for preventing platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD010885. PubMed ID: 29975402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.